ROCKETVAX
RocketVax is a biotech company that develops novel vaccines by incorporating molecular and DNA-based technology.
ROCKETVAX
Industry:
Biotechnology Chemical Health Care Life Science Pharmaceutical
Founded:
2020-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.rocketvax.com
Total Employee:
11+
Status:
Active
Contact:
+41-615-615-421
Email Addresses:
[email protected]
Total Funding:
9.2 M CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Global Site Tag Mobile Non Scaleable Content
Similar Organizations
ARNA Genomics
ARNA Genomics is a biotechnology company that specializes in developing fluid biopsy technology.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Current Advisors List
Current Employees Featured
Founder
Investors List
University Hospital Basel
University Hospital Basel investment in Grant - RocketVax
Canton of Basel-Stadt
Canton of Basel-Stadt investment in Grant - RocketVax
InnoSuisse
InnoSuisse investment in Grant - RocketVax
Official Site Inspections
http://www.rocketvax.com
- Host name: 46.101.141.50
- IP address: 46.101.141.50
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
More informations about "RocketVax" on Search Engine
Swiss Rockets AG announces the founding of ROCKETVAX for โฆ
Nov 10, 2020 For this purpose, Swiss Rockets has founded RocketVax AG in Basel and provides the necessary infrastructure with office and laboratory space as an incubator in cooperation with the Canton of...See details»
RocketVax - Crunchbase Company Profile & Funding
Organization. RocketVax. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. RocketVax is a biotech โฆSee details»
Swiss Rockets AG announces the founding of ROCKETVAX for โฆ
10 Nov, 2020, 09:00 IST. Share this article. BASEL, Switzerland, Nov. 10, 2020 /PRNewswire/ -- The rapid development of an effective and safe vaccine against SARS โฆSee details»
Rocketvax AG | LinkedIn
Rocketvax AG | 758 followers on LinkedIn. Implementing cutting-edge science in next-generation vaccine design that will improve peopleโs lives globally. | The company brings โฆSee details»
New Covid-19 vaccine successfully tested in Switzerland
May 23, 2023 The new vaccine concept, developed in collaboration with the company RocketVax, can also be rapidly adapted to new variants and even to other viruses, the โฆSee details»
Covid-19: Swiss nasal spray vaccine to enter clinical trials
Mar 17, 2022 A Swiss-led research consortium has partnered with Basel-based biotech company RocketVax to launch clinical trials for two second-generation Covid-19 vaccine โฆSee details»
RocketVax - Funding, Financials, Valuation & Investors
RocketVax has raised a total of. CHF5.2M. in funding over 3 rounds. Their latest funding was raised on Aug 3, 2021 from a Grant round. RocketVax is funded by 3 investors. โฆSee details»
RocketVax AG Announces New Milestones in the Development โฆ
Sep 23, 2022 RocketVax AG, a subsidiary of Swiss Rockets AG, partnered up with a broadly supported consortium to accelerate the development of second-generation โฆSee details»
Game-Changing COVID-19 Nasal Vaccine Passes Initial Tests
Apr 10, 2023 The next step is safety testing: The researchers are collaborating with RocketVax AG, a Swiss start-up based in Basel. The biotech company is developing the โฆSee details»
Fresh funds for RocketVax to accelerate second generation โฆ
Jul 2, 2023 Founded in 2019 as a subsidiary of Swiss Rockets AG, RocketVax is a Basel-based biotech company that uses proprietary technologies in molecular biology and โฆSee details»
ROCKETVAX launched to develop a next-generation SARS-CoV โฆ
12.11.2020. Founded as a subsidiary of Swiss Rockets AG, Basel based Rocketvax aims to leverage the DNA synthesis technology acquired from the ETH Zurich spin-off Gigabases โฆSee details»
A new approach to a Covid-19 nasal vaccine shows early promise
Apr 3, 2023 China approves its first mRNA Covid-19 vaccine. One way scientists are trying to do that is by boosting mucosal immunity, beefing up immune defenses in the tissues โฆSee details»
New vaccine concept could lead to a new generation of vaccines โฆ
May 22, 2023 Researchers led by Professor Thomas Klimkait of the Department of Biomedicine at the University of Basel, in collaboration with the company RocketVax, โฆSee details»
Nasal vaccine to prevent COVID-19 passes firs | EurekAlert!
Apr 3, 2023 The next step is safety testing: The researchers are collaborating with RocketVax AG, a Swiss start-up based in Basel. The biotech company is developing the โฆSee details»
Batavia Biosciences to develop innovative clinical process for ...
Jul 6, 2021 RocketVax AG is a Swiss biotech startup based in Basel, founded in summer 2020. RocketVax AG is a subsidiary of Swiss Rockets AG.See details»
An intranasal live-attenuated SARS-CoV-2 vaccine limits virus
Feb 2, 2024 This study was funded by grants from RocketVax Inc., DFG (Deutsche Forschungsgemeinschaft), grant number OS 143/16-1 (to N.O.), and SFB-TR84 Z01b (to โฆSee details»
Swiss Rockets AG announces the founding of ROCKETVAX for โฆ
Nov. 10, 2020, 04:00 AM. BASEL, Switzerland, Nov. 10, 2020 /PRNewswire/ -- The rapid development of an effective and safe vaccine against SARS-CoV-2 is a top priority for โฆSee details»
Seed Round - RocketVax - 2021-08-03 - Crunchbase
Aug 3, 2021 Overview. Organization Name. RocketVax. Announced Date Aug 3, 2021. Funding Type Seed. Funding Stage Seed. Money Raised. CHF2.See details»
RocketVax | EU-Startups
Aug 6, 2021 Business Description. RocketVax is a biotech company that develops novel vaccines by incorporating molecular and DNA-based technology. It is is a Swiss biotech โฆSee details»
Swiss Rockets AG announces the founding of ROCKETVAX for โฆ
Nov 10, 2020 For this purpose, Swiss Rockets has founded RocketVax AG in Basel and provides the necessary infrastructure with office and laboratory space as an incubator in โฆSee details»